We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
-1.9%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$169M
AUM Growth
-$15.1M
Cap. Flow
-$22.7M
Cap. Flow %
-13.45%
Top 10 Hldgs %
33.65%
Holding
197
New
30
Increased
43
Reduced
28
Closed
35

Top Buys

Rank Stock Value
1
ASPN icon
Aspen Aerogels
ASPN
+$3.04M
2
VCNX
Vaccinex, Inc. Common Stock
VCNX
+$2.57M
3
ALIM
Alimera Sciences
ALIM
+$1.96M
4
OUST icon
Ouster
OUST
+$1.74M
5
SILC icon
Silicom
SILC
+$1.63M

Top Sells

Rank Stock Value
1
MCHP icon
Microchip Technology
MCHP
+$5.37M
2
ANIP icon
ANI Pharmaceuticals
ANIP
+$4.71M
3
AVNW icon
Aviat Networks
AVNW
+$1.76M
4
ANVS icon
Annovis Bio
ANVS
+$1.14M
5
CMBM
Cambium Networks
CMBM
+$1.12M

Sector Composition

Rank Sector Weight
1 Healthcare 15.95%
2 Technology 14.24%
3 Financials 7.09%
4 Industrials 3.96%
5 Consumer Staples 1.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITI
26
DELISTED
Iteris, Inc.
ITI
$1.17M 0.69%
282,266
+45,244
+19% +$193K
BAC icon
27
Bank of America
BAC
$435B
$1.16M 0.69%
42,404
+2,131
+5% +$63K
BKTI icon
28
BK Technologies
BKTI
$300M
$1.02M 0.6%
81,951
– –
SRPT icon
29
Sarepta Therapeutics
SRPT
$1.57B
$885K 0.53%
+7,300
New +$825K
CDLX icon
30
Cardlytics
CDLX
$21.7M
$852K 0.51%
5,162
– –
VCNX
31
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$811K 0.48%
51,254
+50,593
+7,654% +$2.57M
BWEN icon
32
Broadwind
BWEN
$93.6M
$793K 0.47%
247,700
– –
ARGX icon
33
argenx
ARGX
$53.4B
$737K 0.44%
+1,500
New +$734K
CLRB icon
34
Cellectar Biosciences
CLRB
$20.5M
$737K 0.44%
9,304
-1,146
-11% -$67.5K
CGTX icon
35
Cognition Therapeutics
CGTX
$79.6M
$733K 0.43%
508,719
– –
NVEC icon
36
NVE Corp
NVEC
$562M
$724K 0.43%
8,813
+1,879
+27% +$158K
CLNN icon
37
Clene
CLNN
$64M
$696K 0.41%
70,214
-3,916
-5% -$54.3K
FENC icon
38
Fennec Pharmaceuticals
FENC
$332M
$696K 0.41%
92,636
-616
-0.7% -$5.01K
SPRB
39
Spruce Biosciences
SPRB
$118M
$683K 0.41%
4,028
+326
+9% +$54.9K
AIRG icon
40
Airgain
AIRG
$73.4M
$662K 0.39%
180,358
– –
TYL icon
41
Tyler Technologies
TYL
$12.7B
$598K 0.35%
1,549
+151
+11% +$59.3K
KPTI icon
42
Karyopharm Therapeutics
KPTI
$43.5M
$598K 0.35%
29,732
– –
ASRT
43
DELISTED
Assertio
ASRT
$591K 0.35%
15,385
+13,852
+904% +$809K
LUV icon
44
Southwest Airlines
LUV
$22B
$590K 0.35%
21,787
+54
+0.2% +$1.76K
MCHP icon
45
Microchip Technology
MCHP
$40.3B
$581K 0.34%
7,438
-64,133
-90% -$5.37M
WEAV icon
46
Weave Communications
WEAV
$520M
$579K 0.34%
71,065
+7,042
+11% +$71.3K
CVV icon
47
CVD Equipment Corp
CVV
$50M
$574K 0.34%
83,739
– –
GSK icon
48
GSK
GSK
$104B
$540K 0.32%
14,900
-18,300
-55% -$650K
COYA icon
49
Coya Therapeutics
COYA
$98.3M
$519K 0.31%
134,006
-12,487
-9% -$49.7K
ADVM
50
DELISTED
Adverum Biotechnologies
ADVM
$498K 0.3%
33,167
-3,901
-11% -$70K
1
2
3 4 5

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
LGM
Lykos Global Management Stamford, Connecticut $30.4M AUM
SCA
SMH Capital Advisors Fort Worth, Texas $32.9M AUM 1.53% 1-Year Est. Return

Worth Venture Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Worth Venture Partners held 197 positions worth $169M, down 8.2% from $184M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Worth Venture Partners withdrew a net $22.7M in Q3 2023, closing 35 positions and reducing 28 holdings. Its most notable exit was ANI Pharmaceuticals, an estimated $4.71M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Technology and Financials.

Against the trend, Worth Venture Partners opened a new position in Aspen Aerogels worth $3.68M.

  • Worth Venture Partners's largest Q3 2023 buy was Aspen Aerogels: 428,367 shares worth $3.68M.
  • Worth Venture Partners added most to Vaccinex, Inc. Common Stock in Q3 2023, an estimated $2.57M increase.
  • Worth Venture Partners's biggest Q3 2023 reduction was Microchip Technology, cutting an estimated $5.37M.
  • Worth Venture Partners fully exited ANI Pharmaceuticals in Q3 2023, selling an estimated $4.71M.
  • Worth Venture Partners's ten largest holdings make up 34% of its $169M portfolio in Q3 2023.
  • Worth Venture Partners opened 30 new positions and closed 35 in Q3 2023.
  • Worth Venture Partners's portfolio value fell 8.2% quarter-over-quarter to $169M.

Based on Worth Venture Partners's 13F filing for Q3 2023, filed 15 Nov 2023.